Recent Updates
Recently added Catalysts

Genfit SA Sponsored ADR

GNFTFDA catalysts, PDUFA dates & pipeline intelligence
$4.85
▲ +0.47 · +10.73%

Last traded Nov 19, 2025. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full GNFT financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $2.5552W HIGH $4.93
Volume
56.95 K
Value Traded
262.91 K
Short % Float
0.08%
Days to Cover
1.6
+14.66%Week
+14.39%1 Month
+17.72%3 Month
+12.01%6 Month
+1.04%5 Year
-77.95%All Time

Cash Data

Unlock GNFT cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
223.46 M
EPS (TTM)
-0.84
P/E Ratio
-
Ent. Value
260.32 M
Total Shares
49.80 M
Float Shares
48.36 M
Insiders
2.90%
Institutions
0.42%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every GNFT catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

GNFT Catalyst Timeline

Dated clinical, regulatory and corporate events for Genfit SA Sponsored ADR

Unlock the full GNFT catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How GNFT actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
2025-12-31VS-01 Phase 2 data readout Phase 2
Unlock 1 more GNFT historical catalyst
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
2
Drugs Scored
rNPV / MCap
Top Drug
Showing 13 of 15 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
NTZ Small moleculeNCT07694297Acute Decompensation of Liver CirrhosisPhase 2 NOT YET_RECRUITING 16Dec 1, 2027
GNS561 Small moleculeNCT05874414CholangiocarcinomaPhase 1/2 RECRUITING 98Jun 1, 2028
Nitazoxanide Small moleculeCompletedNCT05368935Renal ImpairmentPhase 1 COMPLETED 77Sep 9, 2022
Nitazoxanide Small moleculeCompletedNCT05116826Moderate Hepatic ImpairmentPhase 1 COMPLETED 25Apr 13, 2022
Single Dose G1090N Small moleculeCompletedNCT07110441Acute-on-Chronic Liver FailurePhase 1 COMPLETED 52Dec 3, 2025
GFT505 Small moleculeNot countedNCT01271751Atherogenic DyslipidaemiaPhase 2 COMPLETED 96Nov 1, 2009
GFT505 Small moleculeNot countedNCT01271777Insulin ResistancePhase 2 COMPLETED 22Nov 1, 2011
GFT505 Small moleculeNot countedNCT01261494Type II Diabetes MellitusPhase 2 COMPLETED 97Jun 1, 2011
GFT505 Small moleculeNot countedNCT01275469Impaired Glucose TolerancePhase 2 COMPLETED 47Jan 1, 2010
GFT505 Small moleculeNot countedNCT01694849Non-Alcoholic Steatohepatitis (NASH)Phase 2 COMPLETED 275Dec 1, 2015
elafibranor Small moleculeMarketedNCT03124108Primary Biliary Cholangitis (PBC)Approved COMPLETED 45Oct 31, 2018
elafibranor Small moleculeNot countedNCT03844555Kidney DiseasesPhase 1 COMPLETED 23Mar 21, 2020
elafibranor Small moleculeNot countedNCT03765671Liver DiseasePhase 1 COMPLETED 30Jun 14, 2019
Unlock the GNFT pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every GNFT program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every GNFT trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock GNFT insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
No insider trades match the selected filters.
Unlock the full GNFT insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in GNFT

Fund % of Portfolio Current MV Shares Owned Activity
TANG CAPITAL MANAGEMENT LLC 0.2 % (-60 %) 1.85 M 479.44 K -53.93% ( -561.20 K)
Unlock every fund holding GNFT
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in GNFT
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see GNFT ownership
Insider and institutional ownership, quarter by quarter.

GNFT Short Interest

Shares sold short, counted twice a month.

0.08%
Short % of Float
of tradable shares sold short
20.3K
Shares Sold Short
-11.3% vs prior count
1.6 Low
Days to Cover
trading days of normal volume to buy every short share back
13.0K
Avg Daily Volume
the average used for days to cover
Unlock GNFT short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock GNFT option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live GNFT option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock GNFT options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How GNFT ranks across every disease it competes in

Competitive Position is a premium feature
See how GNFT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

GNFT News

About Genfit SA Sponsored ADR

Founded2019
BIOPHARMAWATCH ELITE PLUS
Trade the next GNFT catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime